Print Page    E-mail Page    RSS    E-mail Alerts 

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating & Corporate Governance Committee
Independent Directors
Naseem Amin, M.D. 
Naseem Amin, M.D.
Director


Naseem Amin has broad industry experience in the Biotech and Medical Device industry and served as the Chief Scientific Officer of Smith and Nephew Plc until 2014. Previously, Dr. Amin was Senior Vice President, Business Development at Biogen Idec from 2005 to 2009 and was with Genzyme Corporation from 1999 to 2005, most recently as Head, International Business Development and where he has also led the clinical development of five currently marketed therapeutic products. Dr. Amin began his caree... 
Committee Member   Chairperson
Matthew M. Bennett 
Matthew M. Bennett
Director


Matthew M. Bennett serves as a Managing Director of New Mountain Capital, LLC (“ NMC ”), and he joined that organization in 2007. Mr. Bennett serves on the board of directors of CIOX Health, Gelest, Cytel and Alteon Health and also works closely with other NMC companies. Mr. Bennett previously served as Chief Executive Officer of CIOX Health and before that, he served as Executive Vice President, Global Medical Operations and Chief Legal Officer for Ikaria, Inc. (“ Ikaria ”), where he served in ... 
   Committee Member
Scott P. Bruder, M.D., Ph.D. 
Scott P. Bruder, M.D., Ph.D.
Director


Scott Bruder currently leads Bruder Consulting International with a global team that provides scientific, clinical, regulatory and development strategy services to medical device, regenerative medicine and biotechnology companies, investment banks, venture partners and private equity firms. He is also an adjunct Professor of Biomedical Engineering at Case Western Reserve University, where he previously served as an adjunct faculty member in the Department of Orthopaedic Surgery for thirteen year... 
   Committee Member
Mary Ann Cloyd Financial Expert
Mary Ann Cloyd
Director


Mary Ann Cloyd was a Senior Partner with PricewaterhouseCoopers (PwC) with responsibility for leading PwC’s Center for Board Governance at the time of her retirement in 2015. Ms. Cloyd has over 39 years of public accounting experience serving multinational corporate clients in a variety of industries including biotechnology and pharmaceuticals. Ms. Cloyd has served on both PwC’s Global and US Boards, where she chaired the Risk Management, Ethics & Compliance Committee and the Partner Admissions ... 
Chairperson   Committee Member
Jens Luehring Financial Expert
Jens Luehring
Director


Jens Luehring is the Head of Finance, Americas, of The Linde Group since April 2012. Prior to his current role, Mr. Luehring was the Head of Mergers & Acquisitions of The Linde Group from April 2007 to March 2012. Mr. Luehring received a Master of Business Economics from Hanover University in 1998. Prior to joining The Linde Group in January 2006, Mr. Luehring worked in investment banking, covering corporate finance, private equity, equity capital markets and mergers and acquisitions.... 
Committee Member   
Andre V. Moura 
Andre V. Moura
Director


Andre V. Moura is a Director at New Mountain Capital. Prior to joining New Mountain Capital in 2005, Mr. Moura was employed by McKinsey & Company. Mr. Moura also serves on the board of directors of three privately held companies. Mr. Moura received an A.B. in computer science from Harvard College and an M.B.A. from Harvard Business School.... 
  Chairperson  
Daniel Tassé 
Daniel Tassé
Director


Daniel Tassé is a CEO and Chairman of Alcresta Therapeutics. Prior to the acquisition of Ikaria by Mallinckrodt in April 2015, Mr. Tassé was President and Chief Executive Officer and Chairman of the Board of Ikaria and served as our interim Chief Executive Officer and President from February 2014 to June 2014. Previously, Mr. Tassé was the General Manager of the Pharmaceuticals and Technologies Business Unit of Baxter International, Inc. a global diversified healthcare company and Vice President... 
Committee Member Committee Member